IL6 and Alzheimer disease: As anticipated, we found that IVX treatment reduced caspase-1, TNF-α and IL-6 levels, whereas antagomiR-107/STZ co-treated and STZ-induced AD mice depicted elevated levels of caspase-1 and the inflammatory mediators in the hippocampus.